Pulmonary Neuroendocrine Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-02-11
Clinical Trial Update: Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs) [Phase 3]
Phase 3 trial evaluating tarlatamab vs standard-of-care chemotherapy in pre-treated advanced pulmonary or gastroenteropancreatic poorly diff…